BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28456768)

  • 1. Corticotropin releasing factor receptor 1 antagonist differentially inhibits freezing behavior and changes gamma-aminobutyric acidergic activity in the amygdala in low- and high-anxiety rats.
    Skorzewska A; Wislowska-Stanek A; Lehner M; Turzynska D; Sobolewska A; Krzascik P; Plaznik A
    J Physiol Pharmacol; 2017 Feb; 68(1):35-46. PubMed ID: 28456768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a corticotropin-releasing factor receptor 1 antagonist on the fear conditioning response in low- and high-anxiety rats after chronic corticosterone administration.
    Skórzewska A; Wisłowska-Stanek A; Lehner M; Turzyńska D; Sobolewska A; Krząścik P; Szyndler J; Maciejak P; Płaźnik A
    Stress; 2019 Jan; 22(1):113-122. PubMed ID: 30345859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midazolam treatment before re-exposure to contextual fear reduces freezing behavior and amygdala activity differentially in high- and low-anxiety rats.
    Skórzewska A; Lehner M; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Krząścik P; Płaźnik A
    Pharmacol Biochem Behav; 2015 Feb; 129():34-44. PubMed ID: 25482326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
    Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
    Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.
    Lehner M; Taracha E; Turzyńska D; Sobolewska A; Hamed A; Kołomańska P; Skórzewska A; Maciejak P; Szyndler J; Bidziński A; Płaźnik A
    Behav Brain Res; 2008 Oct; 192(2):203-15. PubMed ID: 18499280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAergic control of the activity of the central nucleus of the amygdala in low- and high-anxiety rats.
    Skórzewska A; Lehner M; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Krząścik P; Płaźnik A
    Neuropharmacology; 2015 Dec; 99():566-76. PubMed ID: 26318100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala.
    Skórzewska A; Bidziński A; Hamed A; Lehner M; Turzyńska D; Sobolewska A; Szyndler J; Maciejak P; Wisłowska-Stanek A; Płaźnik A
    Neuropharmacology; 2009 Aug; 57(2):148-56. PubMed ID: 19477189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.
    Cippitelli A; Ayanwuyi LO; Barbier E; Domi E; Lerma-Cabrera JM; Carvajal F; Scuppa G; Li H; Ubaldi M; Heilig M; Roberto M; Ciccocioppo R
    Psychopharmacology (Berl); 2015 Mar; 232(6):1083-93. PubMed ID: 25260340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing.
    Liu X; Wellman LL; Yang L; Ambrozewicz MA; Tang X; Sanford LD
    Sleep; 2011 Nov; 34(11):1539-49. PubMed ID: 22043125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning.
    Lehner M; Wisłowska-Stanek A; Skórzewska A; Maciejak P; Szyndler J; Turzyńska D; Sobolewska A; Płaźnik A
    Neurobiol Learn Mem; 2010 Nov; 94(4):499-508. PubMed ID: 20833253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear.
    Hubbard DT; Nakashima BR; Lee I; Takahashi LK
    Neuroscience; 2007 Dec; 150(4):818-28. PubMed ID: 17988803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats.
    Skórzewska A; Lehner M; Wisłowska-Stanek A; Krząścik P; Ziemba A; Płaźnik A
    Horm Behav; 2014 Jan; 65(1):6-13. PubMed ID: 24200620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABA(A) mechanism.
    Gondré-Lewis MC; Warnock KT; Wang H; June HL; Bell KA; Rabe H; Tiruveedhula VV; Cook J; Lüddens H; Aurelian L; June HL
    Stress; 2016; 19(2):235-47. PubMed ID: 27023221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T; Nguyen KT; Ehrlich AL; Watkins LR; Spencer RL; Maier SF; Licinio J; Wong ML; Chrousos GP; Webster E; Gold PW
    Endocrinology; 1999 Jan; 140(1):79-86. PubMed ID: 9886810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar effect of CRF
    Spinieli RL; Leite-Panissi CRA
    Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of corticotropin releasing factor in the basolateral amygdala of resilient and vulnerable rats: Effects on fear-conditioned sleep, temperature and freezing.
    Wellman LL; Fitzpatrick ME; Sutton AM; Williams BL; Machida M; Sanford LD
    Horm Behav; 2018 Apr; 100():20-28. PubMed ID: 29501756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice.
    Heldt SA; Mou L; Ressler KJ
    Transl Psychiatry; 2012 Nov; 2(11):e181. PubMed ID: 23149445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of c-Fos and colocalisation of c-Fos and glucocorticoid receptors in brain structures of low and high anxiety rats subjected to extinction trials and re-learning of a conditioned fear response.
    Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
    Neurobiol Learn Mem; 2009 Nov; 92(4):535-43. PubMed ID: 19596457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze.
    Vicentini JE; Céspedes IC; Nascimento JO; Bittencourt JC; Viana MB
    Horm Behav; 2014 Mar; 65(3):195-202. PubMed ID: 24472740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.